|
시장보고서
상품코드
2148412
방사성 의약품 시장 : 유형별, 방사성 동위체별, 용도별, 최종사용자별, 지역별Radiopharmaceuticals Market, By Type, By Radioisotope, By Application, By End User, By Geography |
||||||
방사성 의약품 시장은 2026년에 91억 5,000만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 198억 4,270만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 11.7%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 91억 5,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 11.70% | 2033년 시장 규모 예측 : | 198억 4,270만 달러 |
방사성 의약품이란 영상 진단이나 표적 치료를 위해 의약품 운반체에 결합시킨 방사성동위원소로 구성된 특수 약제입니다. 이들은 특정 조직, 장기 또는 세포 수용체에 선택적으로 축적되어 생리학적 과정을 시각화하거나, 특히 종양학 분야에서 병변 세포에 방사선을 직접 투여할 수 있게 합니다. 이 시장에는 PET 및 SPECT 영상 진단에 사용되는 진단용 약제와 표적 방사성동위원소 치료에 사용되는 치료용 약제가 포함됩니다.
전 세계 방사성 의약품 시장은 암, 심혈관 질환, 신경질환의 유병률 증가에 더해, 핵의학 인프라, 동위원소 생산, 분자 표적 기술의 발전으로 인해 성장하고 있습니다. 표적 치료의 채택 확대에 따라 방사성 의약품의 용도는 기존의 진단 용도를 넘어 확장되고 있지만, 제조, 취급, 유통, 투여에 관한 엄격한 요건은 여전히 이 고도로 전문화된 시장의 특징으로 남아 있습니다.
시장 역학
전 세계 방사성 의약품 시장은 암 및 기타 만성질환의 부담 증가, 표적형 방사성동위원소 요법의 이용 확대, 그리고 양전자 방출 단층촬영(PET) 및 단일 광자 방출 컴퓨터 단층촬영(SPECT)의 응용 확대에 힘입어 성장하고 있습니다. 특히 신흥 시장에서 핵의학 인프라 구축, 동위원소 생산, 차세대 방사성 의약품에 대한 투자 증가도 시장 성장에 기여하는 요인으로 작용하고 있습니다.
그러나 방사성 의약품 시장의 성장은 동위원소의 반감기가 짧다는 점, 공급망이 복잡하다는 점, 규제 요건이 엄격하다는 점, 제조 비용이 높다는 점, 전문 인력이 부족하다는 점 등의 요인에 의해 제약을 받고 있습니다. 그럼에도 불구하고 진단용 영상과 분자 수준에서 맞춤화된 방사성 의약품을 이용한 표적 치료를 결합한 ‘세라노스틱스’ 분야에는 큰 기회가 존재합니다. 악티늄-225 등 알파선을 방출하는 방사성동위원소의 발전, 치료용 파이프라인의 확대, 임상 적응증의 확대, 그리고 제약사, 생명공학 기업, 연구 기관 간의 협력 강화가 시장 성장을 위한 새로운 길을 열어줄 것으로 기대됩니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 규명하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 해설하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하고 있는 경쟁 전략에 관한 중요 인사이트도 제공합니다.
- 본 조사에서는 다음 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 방사성 의약품 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서에서 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- 본 글로벌 방사성 의약품 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 방사성 의약품 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 원활한 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 방사성 의약품 시장 : 유형별, 2021-2033년
제5장 세계의 방사성 의약품 시장 : 방사성 동위체별, 2021-2033년
제6장 세계의 방사성 의약품 시장 : 용도별, 2021-2033년
제7장 세계의 방사성 의약품 시장 : 최종사용자별, 2021-2033년
제8장 세계의 방사성 의약품 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고 문헌 및 조사 방법
KSA 26.10.20Radiopharmaceuticals Market is estimated to be valued at USD 9,150.0 Mn in 2026 and is expected to reach USD 19,842.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 9,150.0 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 11.70% | 2033 Value Projection: | USD 19,842.7 Mn |
Radiopharmaceuticals are special drugs made of radioactive isotopes bound to pharmaceutical vectors for diagnostic imaging and targeted therapy. They selectively gather in specific tissues, organs or cellular receptors to help in the visualization of physiological processes and the delivery of radiation directly to diseased cells, especially in oncology. The market encompasses diagnostic agents used in PET and SPECT imaging and therapeutic agents used in targeted radionuclide therapy.
The global radiopharmaceuticals market is growing due to the rising prevalence of cancer, cardiovascular and neurological disorders, coupled with advances in nuclear medicine infrastructure, isotope production and molecular targeting. The growing adoption of targeted treatments is expanding radiopharmaceuticals beyond traditional diagnostic uses while strict requirements for manufacturing, handling, distribution and administration continue to define this highly specialized market.
Market Dynamics
The global radiopharmaceuticals market is driven by the rise in burden of cancer and other chronic diseases, increasing use of targeted radionuclide therapies and growing applications of positron emission tomography (PET) and single-photon emission computer tomography (SPECT). Rising investments in infrastructure development for nuclear medicine, isotope production and next-generation radiopharmaceuticals especially in emerging markets are other factors contributing to the market growth.
However, the growth of Radiopharmaceuticals market is limited by factors such as short half-life of isotopes, complex supply chains, stringent regulatory requirements, high manufacturing costs and lack of specialized professionals. Nevertheless, significant opportunities exist in theranostics, which combines diagnostic imaging with targeted treatment using molecularly matched radiopharmaceuticals. Advances in alpha-emitting radioisotopes such as Actinium-225, expanding therapeutic pipelines, broader clinical indications, and increasing collaborations among pharmaceutical companies, biotechnology firms, and research institutions are expected to create new avenues for market growth
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global radiopharmaceuticals market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Novartis AG, GE HealthCare Technologies Inc., Cardinal Health, Inc., Curium Pharma, Lantheus Holdings, Inc., Bayer AG, Bracco Imaging S.p.A., Siemens Healthineers AG, Jubilant Pharmova Limited, and Telix Pharmaceuticals Limited
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global radiopharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radiopharmaceuticals market
Market Segmentation
- Type Insights (Revenue, USD Mn, 2021 - 2033)
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
- Radioisotope Insights (Revenue, USD Mn, 2021 - 2033)
- Technetium-99m
- Fluorine-18
- Gallium-68
- Lutetium-177
- Iodine-131
- Actinium-225
- Others
- Application Technique Insights (Revenue, USD Mn, 2021 - 2033)
- Oncology
- Cardiology
- Neurology
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals and Clinics
- Diagnostic Imaging Centers
- Nuclear Medicine Centers
- Academic and Research Institutes
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Novartis AG
- GE HealthCare Technologies Inc.
- Cardinal Health, Inc.
- Curium Pharma
- Lantheus Holdings, Inc.
- Bayer AG
- Bracco Imaging S.p.A.
- Siemens Healthineers AG
- Jubilant Pharmova Limited
- Telix Pharmaceuticals Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Radiopharmaceuticals Market, By Type
- Global Radiopharmaceuticals Market, By Radioisotope
- Global Radiopharmaceuticals Market, By Application
- Global Radiopharmaceuticals Market, By End User
- Global Radiopharmaceuticals Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Industry Trends
4. Global Radiopharmaceuticals Market, By Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Diagnostic Radiopharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Therapeutic Radiopharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Radiopharmaceuticals Market, By Radioisotope, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Technetium-99m
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Fluorine-18
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Gallium-68
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Lutetium-177
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Iodine-131
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Actinium-225
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Radiopharmaceuticals Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Radiopharmaceuticals Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Nuclear Medicine Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Radiopharmaceuticals Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Radioisotope, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE HealthCare Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cardinal Health, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Curium Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lantheus Holdings, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bracco Imaging S.p.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jubilant Pharmova Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Telix Pharmaceuticals Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
